Trump Announces COVID-19 Treatment Advance; Experts Found Mortality Reduction of Up to 35%

The FDA on Sunday issued an “emergency use authorization” for transfusions into COVID-19 patients of plasma donated by those who have recovered from the disease, citing data showing a “significant” – up to 35 percent in some cases – reduction in mortality rates.